Nobuhiro Tsukada

4.1k total citations · 1 hit paper
140 papers, 2.9k citations indexed

About

Nobuhiro Tsukada is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Nobuhiro Tsukada has authored 140 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Hematology, 48 papers in Oncology and 34 papers in Molecular Biology. Recurrent topics in Nobuhiro Tsukada's work include Hematopoietic Stem Cell Transplantation (37 papers), Multiple Myeloma Research and Treatments (30 papers) and Acute Myeloid Leukemia Research (12 papers). Nobuhiro Tsukada is often cited by papers focused on Hematopoietic Stem Cell Transplantation (37 papers), Multiple Myeloma Research and Treatments (30 papers) and Acute Myeloid Leukemia Research (12 papers). Nobuhiro Tsukada collaborates with scholars based in Japan, United States and France. Nobuhiro Tsukada's co-authors include Thomas J. Kipps, Nathan J. Zvaifler, Meike Burger, Marie L. Dell’Aquila, Jan A. Burger, Jan A. Burger, John C. Reed, Shinichi Kitada, Tetsuji Kobata and Yoshifusa Aizawa and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Nobuhiro Tsukada

128 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1

2000 606 citations Jan A. Burger, Nobuhiro Tsukada et al. Blood profile →

Peers

Nobuhiro Tsukada

IMMUN

GENET

HEMAT

ONCOL

Marco Gobbi Italy

Anand S. Lagoo United States

Pearlie K. Epling‐Burnette United States

Fawzia Louache France

Hermine Agis Austria

V. Koneti Rao United States

Hélène Merle‐Béral France

Stefan Früehauf Germany

J D Griffin United States

Gabriela M. Baerlocher Switzerland

Marco Gobbi Italy

Nobuhiro Tsukada

969 ×0.8

IMMUN

896 ×0.8

GENET

1.9k ×2.1

HEMAT

1.0k ×1.4

1.3k ×2.0

ONCOL

Citations per year, relative to Nobuhiro Tsukada Nobuhiro Tsukada (= 1×) peers Marco Gobbi

Countries citing papers authored by Nobuhiro Tsukada

Since Specialization

Citations

This map shows the geographic impact of Nobuhiro Tsukada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiro Tsukada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiro Tsukada more than expected).

Fields of papers citing papers by Nobuhiro Tsukada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiro Tsukada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiro Tsukada. The network helps show where Nobuhiro Tsukada may publish in the future.

Co-authorship network of co-authors of Nobuhiro Tsukada

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiro Tsukada. A scholar is included among the top collaborators of Nobuhiro Tsukada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiro Tsukada. Nobuhiro Tsukada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kikuchi, Taku, Hitoshi Sawada, Yu Abe, et al.. (2025). Can baseline cytomegalovirus IgG titers predict cytomegalovirus reactivation after ide-cel therapy?. Blood Advances. 9(18). 4716–4719.

Iida, Shinsuke, Shigeki Ito, Kazutaka Sunami, et al.. (2025). JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM). International Journal of Hematology. 122(4). 465–509.

Kikuchi, Taku, Nobuhiro Tsukada, Hitoshi Sawada, et al.. (2025). Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple Myeloma. Transplant Infectious Disease. 27(4). e70040–e70040. 3 indexed citations

Quach, Hang, Gurdeep Parmar, Enrique M. Ocio, et al.. (2024). A multicenter, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma. Haematologica. 109(12). 4078–4082. 2 indexed citations

Gaballa, Mahmoud, Nobuhiro Tsukada, Kazuhito Suzuki, et al.. (2024). Real-World Experience with Isatuximab in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM): Iona-MM Second Interim Analysis. Blood. 144(Supplement 1). 2411.5–2411.5. 1 indexed citations

Suzuki, Kazuhito, Yutaka Shimazu, Takashi Ikeda, et al.. (2023). Efficacy of Autologous Stem Cell Transplantation for Myeloma Patients with Suboptimal Response: A Multicenter Retrospective Analysis. Transplantation and Cellular Therapy. 29(11). 688.e1–688.e13. 3 indexed citations

Konuma, Takaaki, Jun Ooi, Hitomi Nagayama, et al.. (2021). Long-term outcomes following the addition of granulocyte colony-stimulating factor-combined high-dose cytarabine to total body irradiation and cyclophosphamide conditioning in single-unit cord blood transplantation for myeloid malignancies. Annals of Hematology. 101(1). 177–189. 3 indexed citations

Shimazu, Yutaka, Shohei Mizuno, Shin‐ichi Fuchida, et al.. (2021). Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine. Cancer Science. 112(12). 5034–5045. 11 indexed citations

Tsukada, Nobuhiro, et al.. (2021). Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study. Drugs - Real World Outcomes. 9(1). 63–78. 3 indexed citations

10.

Mitsutake, Akihiko, et al.. (2018). Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome. Journal of Stroke and Cerebrovascular Diseases. 27(6). e102–e103. 15 indexed citations

11.

Koike, Hiroshi, et al.. (2017). Safety of Daiobotampito in the Treatment of Acute Diverticulitis of the Colon: A Single-Center, Open-Label, Prospective Trial. The Journal of Alternative and Complementary Medicine. 23(11). 885–889.

12.

Terakura, Seitaro, Yoshiko Atsuta, Nobuhiro Tsukada, et al.. (2015). Comparison of Outcomes of 8/8 and 7/8 Allele–Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia. Biology of Blood and Marrow Transplantation. 22(2). 330–338. 79 indexed citations

13.

Mizuki, Akira, Masayuki Tatemichi, Nobuhiro Tsukada, et al.. (2010). Addition of transcatheter arterial chemoembolization decreased local recurrence but had no survival benefit to percutaneous ethanol injection therapy for patients with small hepatocellular carcinoma: A multicenter randomized control study. Oncology Letters. 1(5). 855–859. 8 indexed citations

14.

Konuma, Takaaki, Jun Ooi, Satoshi Takahashi, et al.. (2008). Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCT. Leukemia Research. 33(6). 840–842. 9 indexed citations

15.

Tsukada, Nobuhiro, et al.. (2003). A CASE OF DUODENAL POLYPOID INTRAMUCOSAL ADENOCARCINOMA OBSERVED FOR 6 YEARS. Acta gastro-enterologica belgica. 45(7). 1130–1134.

16.

Burger, Jan A., Nathan J. Zvaifler, Nobuhiro Tsukada, Gary S. Firestein, & Thomas J. Kipps. (2001). Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell–derived factor-1– and CD106 (VCAM-1)–dependent mechanism. Journal of Clinical Investigation. 107(3). 305–315. 153 indexed citations

17.

Burger, Jan A., Nobuhiro Tsukada, Meike Burger, et al.. (2000). Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1. Blood. 96(8). 2655–2663. 606 indexed citations breakdown →

18.

Nakamura, Masahiko, Masaya Oda, Kotaro Kaneko, et al.. (1988). Autoradiographic demonstration of gastrin-releasing peptide-binding sites in the rat gastric mucosa. Gastroenterology. 94(4). 968–976. 19 indexed citations

19.

Tsukada, Nobuhiro, Yoshio Mizuno, Toshiharu Tsuzuki, et al.. (1987). A case of hepatoma which showed a disappearance of multiple pulmonary metastases after transcatheter arterial embolization(TAE) of the tumor.. Kanzo. 28(3). 374–380. 2 indexed citations

20.

Tsukada, Nobuhiro. (1987). Possible involvement of actin filaments in the contraction and dilatation of the hepatic sinusoidal endothelial fenestrae.. Kanzo. 28(12). 1568–1580. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact